Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30664066 | 0.79 | CA12 (0.50) | CA12CA2CA3CA4CA6 | |
| SCHEMBL10621382 | 0.76 | — | — | |
| SCHEMBL20977392 | 0.76 | — | — | |
| SCHEMBL3793843 | 0.76 | KDM4E (0.33) | TDP1 | |
| Tert-Butylamine SCHEMBL4823123 | 0.74 | CA12 (0.36) | CA12CA2CA3CA4CA6 | |
| SCHEMBL7103711 | 0.74 | MAPT (0.35) | ALDH1A1 | |
| SCHEMBL862199 | 0.74 | — | — | |
| SCHEMBL15052995 | 0.74 | CA12 (0.47) | CA12CA2CA3CA4CA6 | |
| SCHEMBL3790948 | 0.72 | MAPT (0.36) | CA12CA9 | |
| Hydrochloric Acid SCHEMBL34473174 | 0.71 | CYP3A4 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3393999-A1 | REACTION RESIN COMPOSITION, MULTI-COMPONENT SYSTEM AND USE THEREOF | Hilti Aktiengesellschaft (LI) | 2018-10-31 | — | — | EP | disclosed |
| WO-2017108553-A1 | REACTION RESIN COMPOSITION, MULTI-COMPONENT SYSTEM AND USE THEREOF | HILTI AKTIENGESELLSCHAFT (LI) | 2017-06-29 | — | — | WO | disclosed |
| EP-3019573-A1 | REACTION RESIN COMPOSITION AND USE THEREOF | Hilti Aktiengesellschaft (LI) | 2016-05-18 | — | — | EP | disclosed |
| WO-2015004175-A1 | REACTION RESIN COMPOSITION AND USE THEREOF | HILTI AKTIENGESELLSCHAFT (LI) | 2015-01-15 | — | — | WO | disclosed |
| EP-2035381-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | Ciba Holding Inc. (CH) | 2009-03-18 | — | — | EP | disclosed |
| EP-2035382-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | Ciba Holding Inc. (CH) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008003602-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003605-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2005090307-A1 | A PROCESS FOR THE SYNTHESIS OF AMINE ETHERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-09-29 | — | — | WO | disclosed |
| US-6900328-B2 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-05-31 | — | — | US | disclosed |
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORP. | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | IL4I1, HCCS, CBR1 | CA12 1443/4885CA2 1563/4885CA3 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.